TY  - JOUR

T1  - Cost-effectiveness (C-E) of tegaserod vs. placebo for treatment of irritable bowel syndrome with constipation (IBS-C)

JO  - VALUE HEALTH

PY  - 2006/05/01

AU  - Akehurst RL

AU  - Sutcliffe P

AU  - Walters S

AU  - Young T

AU  - McBurney C

ED  - 

VL  - 9

IS  - 3

SP  - A45

EP  - A45

Y2  - 2024/12/22

ER  -